X. 3 Coffee
Chlorogenic acid + melanoidin = a polyphenol + fiber-like matrix. Caffeine sensitivity depends on CYP1A2 polymorphism.
Coffee in 1 minute
What does it provide? Chlorogenic acids (CGAs – coffee's main polyphenols, converted by microbiota fermentation into bifidogenic postbiotics), melanoidins (Maillard roasting products, a fermentable "dietary fiber-like" matrix for the colon), caffeine, diterpenes (cafestol, kahweol – cholesterol-raising; in filter coffee the paper filter holds them back).
How much? 1–3 cups (≈ 200–600 ml) daily. Choice: with elevated cholesterol levels, filter coffee (drip / pour-over – the paper filter catches cafestol/kahweol). After 2 pm, choose a decaffeinated variant if you are sensitive.
When to avoid? Severe anxiety, insomnia, pregnancy (moderate), CYP1A2 slow metabolizer, elevated cholesterol (choose filter), active reflux disease.
Coffee's origin begins with an Ethiopian shepherd legend: a goat herder named Kaldi in the Ethiopian Kaffa region around the 9th century noticed that his goats danced wildly after consuming certain reddish berries. The berry beans reached Yemen from the Ethiopian forests, where in the mid-15th century Sufi monks developed the roasted-ground coffee brewing tradition to stay awake during night prayers. By the mid-16th century, the coffee houses of Mecca and Cairo were already venues of learning and political debate, and in 1554 the first coffee house opened in Istanbul, named "Kiva Han" – the Ottoman sultan tried to ban it several times, fearing that coffee houses would become breeding grounds for revolutionary ideas.
In the 17th century, Venetian and London merchants brought coffee to Europe: in 1683, during the siege of Vienna, the retreating Turkish army left behind several hundred sacks of coffee, from which the Polish hero Kulczycki opened the first Viennese coffee house – or so the legend goes. In the 19th century, the spread of Brazilian and Latin American plantations made coffee a global mass commodity, and today the elevated chlorogenic acid content and the melanoidins formed during roasting are at the focus of nutritional science. Genetic work links the ancient (natural-hybrid) origin of arabica to the Ethiopian forests – so Kaldi's goats were telling the truth after all.
Scientific Background
Coffee contains three clinically relevant compound families:
1. Chlorogenic acids (CGAs): Coffee's main polyphenols – esters of caffeic acid and quinic acid. ~ 5–10% in raw coffee beans; partly degraded during roasting. Large amounts of chlorogenic acid reach the colon, where microbiota break it down into phenolic catabolites (caffeic acid, quinic acid, ferulic acid) → postbiotic matrix.
2. Melanoidins: Products of the Maillard reaction (sugar + amino acid at high temperature). Roasting increases melanoidin content. These behave as "antioxidant dietary fiber" – they reach the colon undigested, where they ferment. Dark-roasted coffee is melanoidin-richer; light-roasted is CGA-richer.
3. Caffeine: Adenosine receptor antagonist – increases alertness, focus. Caffeine metabolism depends on CYP1A2 polymorphism: fast metabolizers (~ 40–50% of the population) tolerate 3–4 cups well; slow metabolizers feel the effect with ~ 1–2 cups [1796].
Clinical human evidence:
- Gut motility: Classic manometric studies show that coffee raises rectosigmoid motility index within minutes – even decaffeinated [1791]. In a surgical setting, it accelerates the return of postoperative bowel function.
- Microbiome RCTs:
- 3 cups/day for 3 weeks → Bifidobacterium↑ in healthy adults (human intervention) [304]. - 2024 metagenomic study (n > 22,000): coffee consumption is linked to specific microbial signatures (e.g., Lawsonibacter asaccharolyticus↑) [631].
- Cardiometabolic: In observational cohorts, 2–4 cups/day is associated with lower risk of T2DM, Parkinson's disease, liver cancer [1794]. The causal human RCT evidence is weaker.
Diterpenes: Cafestol and kahweol – they can raise LDL levels. The paper filter retains them → filter coffee is safer from a cholesterol standpoint. Espresso, decoction-style (Turkish, French press) – diterpenes pass through.
Caffeine vs. decaffeinated: Chlorogenic acid and melanoidins remain in decaffeinated coffee – in fact, some studies show that decaf also produces a gut-motility benefit.
- + Fiber-rich diet (oats, legumes, whole grains): fiber + CGA = synbiotic polyphenol matrix.
- + Breakfast meal (NOT on an empty stomach): reduces GI irritation and the cortisol spike.
- + Filtered preparation (drip, Aeropress paper): safer from a cholesterol standpoint.
- + Low-calorie plant milk (almond, coconut): if you want a creamy taste.
- + Live yogurt, kefir at breakfast: multi-fermented diet.
- + Morning-to-midday consumption: sleep-safe caffeine timing.
- Iron supplementation: time separation ≥ 1–2 hours (CGA can chelate).
- Levothyroxine (T4): absorption reduction – separate by ≥ 1 hour.
- MAO inhibitor therapy: caffeine interaction.
- Sugar + creamy syrups: worsens metabolic profile – choose black or with little milk.
- CYP1A2 inducer/inhibitor drugs (e.g., ciprofloxacin): caffeine accumulation.
- Antipsychotic (clozapine): caffeine interaction – medical judgment.
- Severe anxiety, panic disorder: moderate or decaffeinated.
- Insomnia (chronic): not after 2 pm.
- Active reflux disease, gastric ulcer flare: to be avoided on an empty stomach.
- Severe cardiac arrhythmia (atrial fibrillation): caffeine caution.
- Pregnancy: max. 200 mg caffeine/day (≈ 1–2 cups filter) [1795].
- Lactation: caffeine passes into breast milk – moderate due to infant sleep.
- Infant, young child < 12 years: to be avoided.
- CYP1A2 slow metabolizer (genetic): caffeine sensitivity, max. 1–2 cups.
- Elevated LDL cholesterol: choose filter coffee (NOT espresso, NOT decoction).
- Uncontrolled hypertension: moderate.
- Kidney stones (oxalate-type): moderate oxalate – portion control.
Daily serving
1–3 cups (≈ 250–600 ml black coffee) daily. Slow metabolizers: max. 1–2.
Preparation pattern – filter coffee (drip)
- 15 g medium-ground coffee (light-medium roast maximizes CGA).
- 250 ml water at 92–96 °C.
- Paper filter, 3–4 min drawdown.
- Diterpenes stay in the paper.
Classic patterns
Espresso: 7–9 g finely ground, 9 bar, 25–30 sec → 30 ml.
French press: 4 min steep; avoid long standing (bitter).
Cold brew: 100 g coarsely ground + 1 liter cold water + 12–24 hr refrigerator → smooth, low-acid.
Aeropress: filtered, fast – beginner and advanced.
Turkish coffee: finely ground, decocted – high in diterpenes.
Filter latte (with a little milk): filter coffee + 50 ml plant or dairy milk.
Storage
Whole beans: airtight, dark, cool; 1 month optimal-fresh. Ground coffee: 1 week. Never in the refrigerator while opened (moisture, odors).
What not to do
Don't reboil the coffee (bitter). Don't leave in a pot for 1+ hours (acidic, oxidizes). Don't load high-caffeine coffee (energy drink mixes) into your system without knowing your CYP1A2 status.
References
[304] Jaquet M, Rochat I, Moulin J, Cavin C, Bibiloni R. Impact of coffee consumption on the gut microbiota: a human volunteer study. Int J Food Microbiol. 2009. Link
This study assessed the impact of three weeks of moderate instant-coffee consumption (3 cups/day) on the gut microbiota of 16 healthy adult volunteers. Faecal samples were analysed by nucleic-acid-based methods before and after the intervention. The dominant microbiota composition was not significantly altered (Dice similarity 92%), but Bifidobacterium spp. counts increased significantly (P=0.02) and some subjects showed specifically increased Bifidobacterium metabolic activity. The findings indicate that moderate coffee consumption selectively enhances Bifidobacterium activity without disrupting the overall gut community.
[631] Asnicar F, Berry SE, Valdes AM et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat Med. 2021. Link
Deep metagenomic sequencing of 1203 gut microbiomes from 1098 PREDICT-1 individuals (with detailed long-term diet and hundreds of fasting/postprandial cardiometabolic markers) revealed strong associations of microbes with specific nutrients, foods and dietary indices, driven especially by healthy plant-based foods. Microbial obesity biomarkers were reproducible in external cohorts and aligned with circulating cardiovascular blood metabolites. Some microbes (Prevotella copri, Blastocystis spp.) predicted favorable postprandial glucose; overall composition predicted multiple cardiometabolic blood markers. Healthy-diet microbes overlapped with markers of favorable postprandial metabolism, providing a scalable resource for stratifying microbiomes by health level.
[1791] Brown OI et al. Effect of coffee on distal colon function1990;31(4):450–453. Gut. Link
Human study (Gut) on the effect of coffee on distal colon function.
[1794] Poole R et al. Coffee consumption and health: umbrella review of meta-analyses2017;359:j5024. BMJ. Link
Objectives To evaluate the existing evidence for associations between coffee consumption and multiple health outcomes.Design Umbrella review of the evidence across meta-analyses of observational and interventional studies of coffee consumption and any health outcome.Data sources PubMed, Embase, CINAHL, Cochrane Database of Systematic Reviews, and screening of references.Eligibility criteria for selecting studies Meta-analyses of both observational and interventional studies that examined the associations between coffee consumption and any health outcome in any adult population in all countries and all settings. Studies of genetic polymorphisms for coffee metabolism were excluded.Results The umbrella review identified 201 meta-analyses of observational research with 67 unique health outcomes and 17 meta-analyses of interventional research with nine unique outcomes. Coffee consumption was more often associated with benefit than harm for a range of health outcomes across exposures including high versus low, any versus none, and one extra cup a day. There was evidence of a non-linear association between consumption and some outcomes, with summary estimates indicating largest relative risk reduction at intakes of three to four cups a day versus none, including all cause mortality (relative risk 0.83 (95\% confidence interval 0.79 to 0.88), cardiovascular mortality (0.81, 0.72 to 0.90), and cardiovascular disease (0.85, 0.80 to 0.90). High versus low consumption was associated with an 18\% lower risk of incident cancer (0.82, 0.74 to 0.89). Consumption was also associated with a lower risk of several specific cancers and neurological, metabolic, and liver conditions.
[1795] EFSA. Scientific opinion on the safety of caffeine2015;13(5):4102. EFSA Journal. 2015. Link
Scientific Opinion of the EFSA NDA Panel on the safety of caffeine (EFSA Journal 2015;13:4102), assessing caffeine intake from all dietary sources. The Panel concluded that single doses up to 200 mg (about 3 mg/kg bw for a 70-kg adult) and habitual intakes up to 400 mg/day do not raise safety concerns for non-pregnant adults; for pregnant and lactating women habitual intakes up to 200 mg/day do not raise concerns for the fetus or breastfed infant; for children and adolescents the available data are insufficient to derive a safe intake.
[1796] Cornelis MC et al. Coffee, CYP1A2 genotype and risk of myocardial infarction2006. JAMA. Link
CONTEXT: The association between coffee intake and risk of myocardial infarction (MI) remains controversial. Coffee is a major source of caffeine, which is metabolized by the polymorphic cytochrome P450 1A2 (CYP1A2) enzyme. Individuals who are homozygous for the CYP1A2*1A allele are "rapid" caffeine metabolizers, whereas carriers of the variant CYP1A2*1F are "slow" caffeine metabolizers. OBJECTIVE: To determine whether CYP1A2 genotype modifies the association between coffee consumption and risk of acute nonfatal MI. DESIGN, SETTING, AND PARTICIPANTS: Cases (n = 2014) with a first acute nonfatal MI and population-based controls (n = 2014) living in Costa Rica between 1994 and 2004, matched for age, sex, and area of residence, were genotyped by restriction fragment-length polymorphism polymerase chain reaction. A food frequency questionnaire was used to assess the intake of caffeinated coffee.